The reference values of ischemia modified albumin levels in healthy people admitted to a university hospital

Basit Öğe Kaydı
dc.contributor.authorDuman, Can
dc.contributor.authorBakar, Coskun
dc.contributor.authorEssizoglu, Ertan
dc.contributor.authorTutunculer, Funda Kirtay
dc.contributor.authorDemircan, Elif
dc.date.accessioned2025-01-27T20:46:04Z
dc.date.available2025-01-27T20:46:04Z
dc.date.issued2014
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjectives: The Ischemia Modified Albumin (IMA) test is a myocardial ischemia marker which may have potential use for the diagnosis of Acute Coronary Syndrome. The aim of this study was determine reference values of IMA test on the healthy people over the age of 15 who's admitted to canakkale Onsekiz Mart University. Methods: This study was performed on 582 people over 15 years old and healthy in appearance who had presented at the canakkale Onsekiz Mart University Faculty of Medicine Research and Application Hospital. The year 2011 population of Turkey was taken as the reference in the distribution of the study group according to age group and gender. A survey which queried the demographic features and health problems was administered to the participants of the study and 9 cc venous blood was drawn. IMA levels were measured by using the spectrophotometric method defined by Bar-Or. The mean, standard deviation, median, minimum, maximum, and 2.5 % - 97.5 % interval were used in order to detect the IMA reference values. Results: A total of 274 males (47.1 %) and 308 women (52.9 %) were studied. The mean IMA value of the examined group was 0.339 +/- 0.093, and the median was 0.343 (Min-Max: 0.053 - 0.631), while the 2.5 % - 97.5 % percentil values were 0.145 - 0.530. Conclusion: Studies that indicate the reference levels of the IMA for the diagnosis of ischemic conditions are insufficient. Our study is expected to contribute to closing this gap.
dc.identifier.doi10.5505/tjb.2014.32932
dc.identifier.endpage139
dc.identifier.issn0250-4685
dc.identifier.issn1303-829X
dc.identifier.issue2
dc.identifier.scopus2-s2.0-84903765062
dc.identifier.scopusqualityQ3
dc.identifier.startpage132
dc.identifier.urihttps://doi.org/10.5505/tjb.2014.32932
dc.identifier.urihttps://hdl.handle.net/20.500.12428/24803
dc.identifier.volume39
dc.identifier.wosWOS:000338275000003
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWalter De Gruyter Gmbh
dc.relation.ispartofTurkish Journal of Biochemistry-Turk Biyokimya Dergisi
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectIschemia
dc.subjectIschemia-modified albumin
dc.subjectReference range
dc.titleThe reference values of ischemia modified albumin levels in healthy people admitted to a university hospital
dc.title.alternativeBir üniversite hastanesine başvuran sa?li{dotless}kli{dotless} insanlarda iskemi modifiye albuminin referans de?erleri
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu